Wellgistics Health, Inc. to Present at September Investor Conferences
Wellgistics Health (NASDAQ:WGRX), a leader in pharmaceutical distribution and AI-powered hub fulfillment, announced its participation in three upcoming investor conferences in September 2025.
CEO Brian Norton and the executive team will present at the H.C. Wainwright Global Investment Conference on September 8, the NIBA Conference on September 17, and the Skyline Signature Series Webinar on September 30. The presentations will focus on the company's strategic vision, innovations in pharmaceutical distribution, and AI-driven pharmacy fulfillment solutions.
Wellgistics Health (NASDAQ:WGRX), azienda leader nella distribuzione farmaceutica e nella gestione hub con intelligenza artificiale, ha annunciato la partecipazione a tre conferenze per investitori previste a settembre 2025.
Il CEO Brian Norton e il team dirigente presenteranno al H.C. Wainwright Global Investment Conference l'8 settembre, al NIBA Conference il 17 settembre e al Skyline Signature Series Webinar il 30 settembre. Gli interventi illustreranno la visione strategica dell'azienda, le innovazioni nella distribuzione farmaceutica e le soluzioni di fulfillment farmaceutico basate su AI.
Wellgistics Health (NASDAQ:WGRX), líder en distribución farmacéutica y en cumplimiento de pedidos mediante hubs impulsados por IA, anunció su participación en tres conferencias para inversores en septiembre de 2025.
El CEO Brian Norton y el equipo ejecutivo presentarán en el H.C. Wainwright Global Investment Conference el 8 de septiembre, en la NIBA Conference el 17 de septiembre y en el Skyline Signature Series Webinar el 30 de septiembre. Las presentaciones se centrarán en la visión estratégica de la compañía, las innovaciones en distribución farmacéutica y las soluciones de cumplimiento farmacéutico impulsadas por IA.
Wellgistics Health (NASDAQ:WGRX)는 의약품 유통 및 AI 기반 허브 이행 분야의 선도 기업으로, 2025년 9월 개최되는 세 건의 투자자 컨퍼런스에 참가한다고 발표했습니다.
CEO 브라이언 노턴(Brian Norton)과 경영진은 9월 8일 H.C. Wainwright Global Investment Conference, 9월 17일 NIBA Conference, 9월 30일 Skyline Signature Series Webinar에서 발표합니다. 발표 내용은 회사의 전략적 비전, 의약품 유통 혁신 및 AI 기반 약국 이행 솔루션에 중점을 둘 예정입니다.
Wellgistics Health (NASDAQ:WGRX), leader dans la distribution pharmaceutique et le fulfillment en hub piloté par l'IA, a annoncé sa participation à trois conférences investisseurs en septembre 2025.
Le PDG Brian Norton et l'équipe dirigeante présenteront lors du H.C. Wainwright Global Investment Conference le 8 septembre, de la NIBA Conference le 17 septembre et du Skyline Signature Series Webinar le 30 septembre. Les présentations porteront sur la vision stratégique de la société, les innovations dans la distribution pharmaceutique et les solutions de fulfillment pharmaceutique pilotées par l'IA.
Wellgistics Health (NASDAQ:WGRX), ein führendes Unternehmen im Bereich Arzneimittelvertrieb und KI-gestützter Hub-Fulfillment-Lösungen, gab seine Teilnahme an drei Investorenkonferenzen im September 2025 bekannt.
CEO Brian Norton und das Führungsteam werden am H.C. Wainwright Global Investment Conference am 8. September, am NIBA Conference am 17. September und am Skyline Signature Series Webinar am 30. September präsentieren. Die Vorträge fokussieren auf die strategische Ausrichtung des Unternehmens, Innovationen im Arzneimittelvertrieb und KI-basierte Apotheken-Fulfillment-Lösungen.
- None.
- None.
TAMPA, FL / ACCESS Newswire / September 5, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that Brian Norton, Chief Executive Officer, together with members of the Company's executive leadership team, will present at three upcoming investor conferences in September 2025 as follows:
EVENT: H.C. Wainwright 27th Annual Global Investment Conference
DATE: Monday, September 8, 2025
TIME: 1:30 p.m. ET
EVENT: NIBA Conference (Fort Lauderdale, FL)
DATE: Wednesday, September 17, 2025
TIME: To be announced
EVENT: Skyline Signature Series Webinar (Virtual)
DATE: Tuesday, September 30, 2025
TIME: 12:00 p.m. ET
REGISTRATION: Investors may register (for free) at this link.
These events provide valuable opportunities for Wellgistics Health to showcase its strategic vision, highlight ongoing innovations in pharmaceutical distribution and AI-driven pharmacy fulfillment, and connect directly with the investment community
"Participating in these high-caliber investor events is important for expanding Wellgistics Health's visibility. They give us a chance to engage with current and prospective shareholders and build relationships with strategic partners who can help accelerate our growth," commented Brian Norton, CEO of Wellgistics Health.
About Wellgistics Health
Wellgistics Health delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies with 200+ U.S. manufacturers, offering services such as wholesale distribution, digital prescription routing, and AI-powered hub services-including eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health is restoring access, transparency, and trust in U.S. healthcare.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, market conditions and other risks detailed in our reports and statements filed with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.
Media Contact:
media@wellgisticshealth.com
Investor Relations:
investors@wellgisticshealth.com
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Wellgistics Health (WGRX) presenting at the H.C. Wainwright Conference?
What investor conferences is Wellgistics Health (WGRX) attending in September 2025?
How can investors attend Wellgistics Health's Skyline Signature Series presentation?
What will Wellgistics Health (WGRX) discuss at these investor conferences?
